U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07946913) titled 'A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic Despite Treatment With H1 Antihistamines' on Nov. 09.
Brief Summary: This is a multicenter, randomized, double-blind, active-controlled Phase III clinical study to evaluate the safety and efficacy of LP-003 injection in patients with chronic spontaneous urticaria who remain symptomatic despite treatment with H1 antihistamines.
Study Start Date: Dec. 07
Study Type: INTERVENTIONAL
Condition:
Chronic Spontaneous Urticaria (CSU)
Intervention:
BIOLOGICAL: LP-003 Injection
s.c. injection
BIOLOGICAL:...